Logos Global Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-500,000
| Closed | -$11.6M | – | 54 |
|
|
2024
Q4 | $11.6M | Buy |
500,000
+300,000
| +150% | +$6.98M | 1.36% | 27 |
|
|
2024
Q3 | $5.88M | Sell |
200,000
-375,000
| -65% | -$11M | 0.63% | 35 |
|
|
2024
Q2 | $13.5M | Buy |
575,000
+325,000
| +130% | +$7.64M | 1.09% | 26 |
|
|
2024
Q1 | $9.48M | Buy |
250,000
+100,000
| +67% | +$3.79M | 0.77% | 29 |
|
|
2023
Q4 | $3.23M | Sell |
150,000
-60,000
| -29% | -$1.29M | 0.3% | 42 |
|
|
2023
Q3 | $2.57M | Buy |
210,000
+84,285
| +67% | +$1.03M | 0.34% | 44 |
|
|
2023
Q2 | $1.42M | Buy |
+125,715
| New | +$1.42M | 0.19% | 46 |
|